Sildenafil
Product Images NDC 17224-460

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 17224-460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Calvin, Scott And Company, Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

Prescription medication label for Phentermine 37.5 mg tablets. The label includes directions to take one tablet each morning or as directed, and notes the product is a Schedule IV controlled substance. The label also states the product contains 28 white/blue speck tablets with expiration 09/20, distributed by Calvin Scott & Co. Inc., Albuquerque, NM.*

FDA Label Image

Figure-10 (Sildenafil Fig 10)

A forest plot chart showing placebo-corrected changes in 6-minute walk distance (meters) for Sildenafil 20 mg taken three times daily (TID) across various subgroups such as baseline walk distance, etiology, pulmonary hypertension classification, gender, age, mean pulmonary artery pressure, and pulmonary vascular resistance index. The chart illustrates group sizes, mean differences, and confidence intervals for each subgroup.*

FDA Label Image

Figure-11 (Sildenafil Fig 11)

A Kaplan-Meier survival curve chart depicting the percentage of subjects without a clinically worsening event over days from randomization. The graph compares two groups labeled as Placebo and Sildenafil, with percentage on the y-axis and day count on the x-axis, showing differences in event progression over time.*

FDA Label Image

Fig-12 (Sildenafil Fig 12)

A line graph depicting the mean change from baseline in meters over a 12-week study period for three Sildenafil dose groups: 1 mg TID, 5 mg TID, and 20 mg TID. The Y-axis shows change from baseline ranging from -10 to 70 meters, and the X-axis represents study weeks 4, 8, and 12. Data points include standard error bars for each dose group at each time point.*

FDA Label Image

Fig-6 (Sildenafil Fig 6)

A survival curve chart depicting estimated cumulative mortality rates over 5 years for three dosing groups labeled High dose, Medium dose, and Low dose. The X-axis represents time in years, and the Y-axis shows mortality percentage. The chart includes the number of participants at risk over time for each dose group.*

FDA Label Image

Fig-8 (Sildenafil Fig 8)

A forest plot chart titled 'Interacting Drug Acenocoumarol' showing fold change and 90% confidence intervals for various drugs in relation to their interaction with Sildenafil. The chart lists drugs on the vertical axis and indicates changes in parameters such as INR AUC, INR Cmax, AUC, Cmax, and bleeding time, with recommendations on dose adjustments for each drug. Most drugs show 'No dose adjustment' recommended, except for Ritonavir which advises against coadministration.*

FDA Label Image

Figure-9 (Sildenafil Fig 9)

A line graph depicting changes from baseline in meters over 12 weeks in a study. The x-axis represents weeks 4, 8, and 12 of the study, and the y-axis represents change from baseline in meters. Data for placebo, sildenafil 20 mg TID, sildenafil 40 mg TID, and sildenafil 80 mg TID are shown with different symbols and error bars indicating variability.*

FDA Label Image

Figure-7 (Sildenafil Figure 7)

A chart depicting fold change and 90% confidence intervals for various interacting drugs relative to Sildenafil alone. It shows changes in AUC and Cmax for drugs including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir, alongside corresponding dosage adjustment recommendations.*

FDA Label Image

Str (Sildenafil Str)

Chemical structure of Sildenafil showing its molecular components, including a sulfonyl group attached to a benzene ring, a pyrazolo-pyrimidinone core, and a piperazine ring with ethoxy and carboxyl functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.